Shengnuo Pharmaceutical-B (02257) was increased by 100,000 shares by Chairman Pan Honghui

Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257) announced that Dr. Pan Honghui, the company's executive director and chairman, purchased a total of 100,000 shares of the company's common shares on the open market with his personal capital at an average price of about HK$6.83 per share. The total cost is about HK$683,000. Following the purchase, Dr. Pan Honghui held an interest in a total of 17,627,696 shares, accounting for 16.44% of the company's total issued share capital on the date of this announcement.

According to Dr. Pan Honghui, he is confident about the Group's overall development prospects and potential growth. Subject to applicable laws and regulatory requirements, Dr. Pan Honghui does not rule out that he may further increase his shareholding in the company in due course.